Skip to main content
SpringerLink
Log in

Use of Stem Cells in the Treatment of Erectile Dysfunction

  • Chapter
  • First Online:
Stem Cell Therapy for Vascular Diseases

  • 459 Accesses

Abstract

The use of stem cell therapy in the treatment of erectile dysfunction has been tested in both animal models and humans. The rationale for its use involves the regenerative properties of these cells to restore function to damaged cells and tissues via differentiation into healthy cells or to exert its paracrine effects to immunomodulate through secretion of cytokines and growth factors. We herein review the published data regarding effects of stem cells on erectile dysfunction and comment on the current state of clinical use/overuse of this treatment at the present time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151(1):54–61.

    Article  CAS  PubMed  Google Scholar 

  2. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–7.

    Article  PubMed  Google Scholar 

  3. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men’s Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20(5):607–17.

    Article  PubMed  Google Scholar 

  4. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003;139(3):161–8.

    Article  PubMed  Google Scholar 

  5. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12(6):305–11.

    Article  CAS  PubMed  Google Scholar 

  6. Schulster ML, Liang SE, Najari BB. Metabolic syndrome and sexual dysfunction. Curr Opin Urol. 2017;27(5):435–40.

    Article  PubMed  Google Scholar 

  7. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Thomas S, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc. 2001;49(4):436–42.

    Article  CAS  PubMed  Google Scholar 

  8. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–49.

    Article  PubMed  Google Scholar 

  9. Rosen RC, Seidman SN, Menza MA, Shabsigh R, Roose SP, Tseng LJ, et al. Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms. Int J Impot Res. 2004;16(4):334–40.

    Article  CAS  PubMed  Google Scholar 

  10. Nicolosi A, Glasser DB, Moreira ED, Villa M. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res. 2003;15(4):253–7.

    Article  CAS  PubMed  Google Scholar 

  11. Rosen RC, Wing R, Schneider S, Gendrano N. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin N Am. 2005;32(4):403–17.

    Article  Google Scholar 

  12. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978–84.

    Article  CAS  PubMed  Google Scholar 

  13. Impotence: NIH Consensus Development Panel on Impotence. JAMA. 1993;270(1):83–90.

    Article  Google Scholar 

  14. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998;13(3):159–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States prevalence and predictors. JAMA. 1999;281(6):537–44.

    Article  CAS  PubMed  Google Scholar 

  16. Sattar AA, Wespes E, Schulman CC. Computerized measurement of penile elastic fibres in potent and impotent men. Eur Urol. 1994;25(2):142–4.

    Article  CAS  PubMed  Google Scholar 

  17. Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am. 2005;32(4):379.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. In: Wein AJK, Louis R, Partin AW, Peters CA, editors. Campbell-Walsh urology. Philadelphia, PA, USA: Elsevier. 2016. p. 612–42.e9.

    Google Scholar 

  19. de Groat WC, Booth A. Neural control of penile erection. In: Maggi C, editor. The autonomic nervous system. London, UK: Academic Publishers; 1993. p. 465–513.

    Google Scholar 

  20. Giuliano F. Neurophysiology of erection and ejaculation. J Sex Med. 2011;8:310–5.

    Article  PubMed  Google Scholar 

  21. Halata Z, Munger BL. The neuroanatomical basis for the protopathic sensibility of the human glans penis. Brain Res. 1986;371(2):205–30.

    Article  CAS  PubMed  Google Scholar 

  22. McKenna KE. Central control of penile erection. Int J Impot Res. 1998;10(Suppl 1):S25–34.

    PubMed  Google Scholar 

  23. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 1990;170(2):843–50.

    Article  CAS  PubMed  Google Scholar 

  24. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest. 1991;88(1):112–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci U S A. 2002;99(6):4061–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet (London, England). 2007;369(9561):597–611.

    Article  CAS  Google Scholar 

  27. Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol. 1997;158(5):1764–7.

    Article  CAS  PubMed  Google Scholar 

  28. Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, et al. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med. 2007;4(5):1485–93.

    Article  CAS  PubMed  Google Scholar 

  29. Guay AT, Traish A. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction. Urol Clin North Am. 2011;38(2):175–83.

    Article  PubMed  Google Scholar 

  30. Francis ME, Kusek JW, Nyberg LM, Eggers PW. The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol. 2007;178(2):591–6.

    Article  PubMed  Google Scholar 

  31. Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev. 1999;18(1):5–24.

    CAS  PubMed  Google Scholar 

  32. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl. 2003;24(2):239–45.

    Article  PubMed  Google Scholar 

  33. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol. 2003;169(3):1175–9.

    Article  PubMed  Google Scholar 

  34. Biering-Sorensen F, Sonksen J. Sexual function in spinal cord lesioned men. Spinal Cord. 2001;39(9):455–70.

    Article  CAS  PubMed  Google Scholar 

  35. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8(5):464–74.

    Article  CAS  PubMed  Google Scholar 

  36. Jeon SW, Yoo KH, Kim TH, Kim JI, Lee CH. Correlation of the erectile dysfunction with lesions of cerebrovascular accidents. J Sex Med. 2009;6(1):251–6.

    Article  PubMed  Google Scholar 

  37. Jung JH, Kam SC, Choi SM, Jae SU, Lee SH, Hyun JS. Sexual dysfunction in male stroke patients: correlation between brain lesions and sexual function. Urology. 2008;71(1):99–103.

    Article  PubMed  Google Scholar 

  38. Rowland DL, Greenleaf W, Mas M, Myers L, Davidson JM. Penile and finger sensory thresholds in young, aging, and diabetic males. Arch Sex Behav. 1989;18(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  39. Borchers H, Brehmer B, Kirschner-Hermanns R, Reineke T, Tietze L, Jakse G. Erectile function after non-nerve-sparing radical prostatectomy: fact or fiction? Urol Int. 2006;76(3):213–6.

    Article  PubMed  Google Scholar 

  40. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128(3):492–7.

    Article  CAS  PubMed  Google Scholar 

  41. Weinstein M, Roberts M. Sexual potency following surgery for rectal carcinoma. A followup of 44 patients. Ann Surg. 1977;185(3):295–300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol. 1990;143(3):538–43; discussion 44.

    Article  CAS  PubMed  Google Scholar 

  43. Kendirci M, Hellstrom WJ. Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer. 2004;3(2):87–92.

    Article  PubMed  Google Scholar 

  44. Liang J-T, Lai H-S, Lee P-H, Chang K-J. Laparoscopic pelvic autonomic nerve-preserving surgery for sigmoid colon cancer. Ann Surg Oncol. 2008;15(6):1609–16.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol. 1991;145(5):998–1002.

    Article  CAS  PubMed  Google Scholar 

  46. Tal R, Valenzuela R, Aviv N, Parker M, Waters WB, Flanigan RC, et al. Persistent erectile dysfunction following radical prostatectomy: the association between nerve-sparing status and the prevalence and chronology of venous leak. J Sex Med. 2009;6(10):2813–9.

    Article  PubMed  Google Scholar 

  47. Vale J. Erectile dysfunction following radical therapy for prostate cancer. Radiother Oncol. 2000;57(3):301–5.

    Article  CAS  PubMed  Google Scholar 

  48. Walsh PC, Brendler CB, Chang T, Marshall FF, Mostwin JI, Stutzman R, et al. Preservation of sexual function in men during radical pelvic surgery. Maryland Med J (Baltimore, Md : 1985). 1990;39(4):389–93.

    CAS  Google Scholar 

  49. Nelson CJ, Scardino PT, Eastham JA, Mulhall JP. Back to baseline: erectile function recovery after radical prostatectomy from the patients’ perspective. J Sex Med. 2013;10(6):1636–43.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Ziegler D. Diagnosis and treatment of diabetic autonomic neuropathy. Curr Diab Rep. 2001;1(3):216–27.

    Article  CAS  PubMed  Google Scholar 

  51. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166(2):569–74; discussion 74-5.

    Article  CAS  PubMed  Google Scholar 

  52. Shabsigh R, Fishman IJ, Schum C, Dunn JK. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology. 1991;38(3):227–31.

    Article  CAS  PubMed  Google Scholar 

  53. Christ GJ, Maayani S, Valcic M, Melman A. Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol. 1990;101(2):375–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Toda N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther. 2012;133(2):159–76.

    Article  CAS  PubMed  Google Scholar 

  55. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000;56(2):302–6.

    Article  CAS  PubMed  Google Scholar 

  56. Esposito K, Ciotola M, Giugliano F, Maiorino MI, Autorino R, De Sio M, et al. Effects of intensive lifestyle changes on erectile dysfunction in men. J Sex Med. 2009;6(1):243–50.

    Article  CAS  PubMed  Google Scholar 

  57. Esposito K, Giugliano F, De Sio M, Carleo D, Di Palo C, D'Armiento M, et al. Dietary factors in erectile dysfunction. Int J Impot Res. 2006;18(4):370–4.

    Article  CAS  PubMed  Google Scholar 

  58. Belardinelli R, Lacalaprice F, Faccenda E, Purcaro A, Perna G. Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure. Int J Cardiol. 2005;101(1):83–90.

    Article  PubMed  Google Scholar 

  59. Kolotkin RL, Binks M, Crosby RD, Ostbye T, Mitchell JE, Hartley G. Improvements in sexual quality of life after moderate weight loss. Int J Impot Res. 2008;20(5):487–92.

    Article  CAS  PubMed  Google Scholar 

  60. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397–404.

    Article  CAS  PubMed  Google Scholar 

  61. Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902–12.

    Article  CAS  PubMed  Google Scholar 

  62. Giuliano F, Jackson G, Montorsi F, Martin-Morales A, Raillard P. Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract. 2010;64(2):240–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Card GL, England BP, Suzuki Y, Fong D, Powell B, Lee B, et al. Structural basis for the activity of drugs that inhibit Phosphodiesterases. Structure. 2004;12(12):2233–47.

    Article  CAS  PubMed  Google Scholar 

  64. Corbin JD. Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res. 2004;16(Suppl 1):S4–7.

    Article  CAS  PubMed  Google Scholar 

  65. Jeon YH, Heo YS, Kim CM, Hyun YL, Lee TG, Ro S, et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci. 2005;62(11):1198–220.

    Article  CAS  PubMed  Google Scholar 

  66. Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S, et al. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013;10(1):130–71.

    Article  CAS  PubMed  Google Scholar 

  67. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al. Efficacy and safety of Tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Part 1):1332–6.

    Article  CAS  PubMed  Google Scholar 

  68. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. 2002;23(6):763–71.

    CAS  PubMed  Google Scholar 

  69. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192–9.

    Article  CAS  PubMed  Google Scholar 

  70. Smith WB, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013;67(8):768–80.

    Article  CAS  PubMed  Google Scholar 

  71. Brock G, Nehra A, Lipshultz LI, Karlin GS, Gleave M, Seger M, et al. Safety and efficacy of Vardenafil for the treatment of men with erectile dysfunction after radical Retropubic prostatectomy. J Urol. 2003;170(4 Part 1):1278–83.

    Article  CAS  PubMed  Google Scholar 

  72. Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med. 2005;2(5):658–67.

    Article  CAS  PubMed  Google Scholar 

  73. Montorsi F, Nathan HP, Mccullough A, Brock GB, Broderick G, Ahuja S, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol. 2004;172(3):1036–41.

    Article  CAS  PubMed  Google Scholar 

  74. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999;281(5):421–6.

    Article  CAS  PubMed  Google Scholar 

  75. Kang SG, Kim JJ. Udenafil: efficacy and tolerability in the management of erectile dysfunction. Ther Adv Urol. 2013;5(2):101–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Kedia GT, Uckert S, Assadi-Pour F, Kuczyk MA, Albrecht K. Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. Ther Adv Urol. 2013;5(1):35–41.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Corona G, Razzoli E, Forti G, Maggi M. The use of phosphodiesterase 5 inhibitors with concomitant medications. J Endocrinol Investig. 2008;31(9):799–808.

    Article  CAS  Google Scholar 

  78. Burnett A. Evaluation and management of erectile dysfunction. In: Wein AJK, Louis R, Partin AW, Peters CA, editors. Campbell-Walsh urology. Philadelphia, PA, USA: Elsevier. 2016. p. 643–68.e7.

    Google Scholar 

  79. Virag R. Intracavernous injection of papaverine for erectile failure. 1982. J Urol. 2002;167(2 Pt 2):1196.

    Article  CAS  PubMed  Google Scholar 

  80. Palmer LS, Valcic M, Melman A, Giraldi A, Wagner G, Christ GJ. Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells. J Urol. 1994;152(4):1308–14.

    Article  CAS  PubMed  Google Scholar 

  81. Seyam R, Mohamed K, Akhras AA, Rashwan H. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1. Int J Impot Res. 2005;17(4):346–53.

    Article  CAS  PubMed  Google Scholar 

  82. Soderdahl DW, Thrasher JB, Hansberry KL. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. Br J Urol. 1997;79(6):952–7.

    Article  CAS  PubMed  Google Scholar 

  83. Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study. Urology. 2000;55(1):109–13.

    Article  CAS  PubMed  Google Scholar 

  84. Shokeir AA, Alserafi MA, Mutabagani H. Intracavernosal versus intraurethral alprostadil: a prospective randomized study. BJU Int. 1999;83(7):812–5.

    Article  CAS  PubMed  Google Scholar 

  85. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med. 1996;334(14):873–7.

    Article  CAS  PubMed  Google Scholar 

  86. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633–41.

    Article  PubMed  Google Scholar 

  87. Brison D, Seftel A, Sadeghi-Nejad H. The resurgence of the Vacuum Erection Device (VED) for treatment of erectile dysfunction. J Sex Med. 2013;10(4):1124–35.

    Article  PubMed  Google Scholar 

  88. Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama a Nijeholt GA, et al. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group. Br J Urol. 1998;81(6):889–94.

    Article  PubMed  Google Scholar 

  89. Akdemir F, Okulu E, Kayigil O. Long-term outcomes of AMS Spectra(R) penile prosthesis implantation and satisfaction rates. Int J Impot Res. 2017;29(5):184–8.

    Article  CAS  PubMed  Google Scholar 

  90. Akakpo W, Pineda MA, Burnett AL. Critical analysis of satisfaction assessment after penile prosthesis surgery. Sex Med Rev. 2017;5(2):244–51.

    Article  PubMed  Google Scholar 

  91. Levine LA, Becher EF, Bella AJ, Brant WO, Kohler TS, Martinez-Salamanca JI, et al. Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med. 2016;13(4):489–518.

    Article  PubMed  Google Scholar 

  92. Carson CC 3rd, Mulcahy JJ, Harsch MR. Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol. 2011;185(2):614–8.

    Article  PubMed  Google Scholar 

  93. Serefoglu EC, Mandava SH, Gokce A, Chouhan JD, Wilson SK, Hellstrom WJ. Long-term revision rate due to infection in hydrophilic-coated inflatable penile prostheses: 11-year follow-up. J Sex Med. 2012;9(8):2182–6.

    Article  CAS  PubMed  Google Scholar 

  94. Enemchukwu EA, Kaufman MR, Whittam BM, Milam DF. Comparative revision rates of inflatable penile prostheses using woven Dacron(R) fabric cylinders. J Urol. 2013;190(6):2189–93.

    Article  PubMed  Google Scholar 

  95. Zhang H, Albersen M, Jin X, Lin G. Stem cells: novel players in the treatment of erectile dysfunction. Asian J Androl. 2012;14(1):145–55.

    Article  PubMed  Google Scholar 

  96. Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016;2016:24.

    Article  Google Scholar 

  97. Ding D-C, Chang Y-H, Shyu W-C, Lin S-Z. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339–47.

    Article  PubMed  Google Scholar 

  98. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.

    Article  CAS  PubMed  Google Scholar 

  99. Lin C, Shih D, editors. Green consumption attitudes of the tourists lodging in the resort hotel. 2010 4th international conference on bioinformatics and biomedical engineering, 2010, 18–20 June.

    Google Scholar 

  100. Peak TC, Anaissie J, Hellstrom WJG. Current perspectives on stem cell therapy for erectile dysfunction. Sex Med Rev. 2016;4(3):247–56.

    Article  PubMed  Google Scholar 

  101. Xin Z-C, Xu Y-D, Lin G, Lue T, Guo Y-L. Recruiting endogenous stem cells: a novel therapeutic approach for erectile dysfunction. Asian J Androl. 2016;18(1):10–5.

    Article  CAS  PubMed  Google Scholar 

  102. Shan H, Chen F, Zhang T, He S, Xu L, Wei A. Stem cell therapy for erectile dysfunction of cavernous nerve injury rats: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0121428-e.

    Article  Google Scholar 

  103. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004;94(6):904–9.

    Article  PubMed  Google Scholar 

  104. Kendirci M, Trost L, Bakondi B, Whitney MJ, Hellstrom WJG, Spees JL. Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a Rat Model of cavernous nerve injury. J Urol. 2010;184(4):1560–6.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Te AE, Santarosa RP, Koo HP, Buttyan R, Greene LA, Kaplan SA, et al. Neurotrophic factors in the rat penis. J Urol. 1994;152(6 Pt 1):2167–72.

    Article  CAS  PubMed  Google Scholar 

  106. Ryu JK, Kim DH, Song KM, Yi T, Suh JK, Song SU. Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a Mouse Model of cavernous nerve injury. J Sex Med. 2014;11(2):411–23.

    Article  PubMed  Google Scholar 

  107. Xu Y, Guan R, Lei H, Li H, Wang L, Gao Z, et al. Therapeutic potential of adipose-derived stem cells-based micro-tissues in a rat model of postprostatectomy erectile dysfunction. J Sex Med. 2014;11(10):2439–48.

    Article  CAS  PubMed  Google Scholar 

  108. Lin H, Dhanani N, Tseng H, Souza GR, Wang G, Cao Y, et al. Nanoparticle improved stem cell therapy for erectile dysfunction in a Rat Model of cavernous nerve injury. J Urol. 2016;195(3):788–95.

    Article  CAS  PubMed  Google Scholar 

  109. Ouyang B, Sun X, Han D, Chen S, Yao B, Gao Y, et al. Human urine-derived stem cells alone or genetically-modified with FGF2 improve type 2 diabetic erectile dysfunction in a Rat Model. PLoS One. 2014;9(3):e92825.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Position statement: ED restorative (regenerative) therapies (shock waves, autologous platelet rich plasma, and stem cells). Available from: https://www.smsna.org/V1/resources/position-statements.

  111. Bahk JY, Jung JH, Han H, Min SK, Lee YS. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant. 2010;8(2):150–60.

    PubMed  Google Scholar 

  112. Yiou R, Hamidou L, Birebent B, Bitari D, Lecorvoisier P, Contremoulins I, et al. Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: an open dose-escalation pilot study. Eur Urol. 2016;69(6):988–91.

    Article  PubMed  Google Scholar 

  113. Yiou R, Hamidou L, Birebent B, Bitari D, Le Corvoisier P, Contremoulins I, et al. Intracavernous injections of bone marrow mononucleated cells for postradical prostatectomy erectile dysfunction: final results of the INSTIN clinical trial. Eur Urol Focus. 2017;3(6):643–5.

    Article  PubMed  Google Scholar 

  114. Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP. Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells. J Am Osteopath Assoc. 2016;116(1):e1–5.

    PubMed  Google Scholar 

  115. Lin CS, Xin ZC, Wang Z, Deng C, Huang YC, Lin G, et al. Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev. 2012;21(3):343–51.

    Article  CAS  PubMed  Google Scholar 

  116. FDA warns about stem cell therapies. [Available from: https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies.

  117. Carson CC, Kirby R, Goldstein I. Textbook of erectile dysfunction. Oxford, UK: Isis Medical Media Ltd; 1999. p. 26.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Yale School of Medicine, New Haven, CT, USA

    Benjamin Press

  2. Department of Urology, Yale School of Medicine, New Haven, CT, USA

    Stanton C. Honig

Authors
  1. Benjamin Press
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stanton C. Honig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stanton C. Honig .

Editor information

Editors and Affiliations

  1. Department of Surgery, Vascular Surgery Section, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

    Tulio Pinho Navarro

  2. Postgraduate Program in Sciences Applied to Surgery, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

    Lara Lellis Navarro Minchillo Lopes

  3. Vascular Biology and Therapeutics Program and the Departments of Surgery and Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA

    Alan Dardik

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Press, B., Honig, S.C. (2021). Use of Stem Cells in the Treatment of Erectile Dysfunction. In: Navarro, T.P., Minchillo Lopes, L.L.N., Dardik, A. (eds) Stem Cell Therapy for Vascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-56954-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56954-9_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56953-2

  • Online ISBN: 978-3-030-56954-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation